Selective cyclooxygenase-2 inhibition produces heterogeneous erythema response to ultraviolet irradiation

J Invest Dermatol. 2005 Dec;125(6):1317-20. doi: 10.1111/j.0022-202X.2005.23960.x.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Celecoxib
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Erythema / radiotherapy*
  • Humans
  • Membrane Proteins / metabolism*
  • Proliferating Cell Nuclear Antigen / analysis
  • Pyrazoles / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • Cyclooxygenase Inhibitors
  • Membrane Proteins
  • Proliferating Cell Nuclear Antigen
  • Pyrazoles
  • Sulfonamides
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Celecoxib